Funding opportunities
2,259 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Dynamic Regulation of Epidermal Differentiation Genes by Cell-State-Specific PBAF InteractomeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 4/30/2031up to $524,335activenih
- Long-term Impacts and Mechanisms of Financial Programming on Mental Health of Young AdultsNational Institute of Nursing ResearchRFA-NR-25-004 closes 4/30/2031up to $836,590activenih
- Early Re-Initiation of Semaglutide After Metabolic and Bariatric Surgery in Youth: A Randomized Clinical TrialNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-305 closes 4/30/2031up to $884,146activenih
- Psychosocial Stress in Early Life, Chronodisruption and Accelerated Aging in Mid Life: A Life-course ApproachNational Institute on AgingPA-25-301 closes 4/30/2031up to $646,620activenih
- JMJD3 as a transducer of environmental signals in the regenerative nicheNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 4/30/2031up to $553,640activenih
- Integrating Flexible Electronics and Optogenetics for Real-Time Arrhythmic Profiling of Engineered Heart TissuesNational Heart Lung and Blood InstitutePA-25-301 closes 4/30/2031up to $696,259activenih
- Living, Iterative Validation and Evaluation of AI in MedicineNational Library of MedicinePA-25-301 closes 4/30/2031up to $652,850activenih
- Mechanisms of placental mimicry cell therapyNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 4/30/2031up to $742,634activenih
- Administrative CoreNational Institute of Allergy and Infectious DiseasesPAR-22-225 closes 4/30/2031up to $62,240activenih
- Factors Driving Wear and Implant Failure in Total Shoulder ArthroplastyNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-25-301 closes 4/30/2031up to $643,185activenih
- The roles of P2RY8 in B cell tolerance and traffickingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesPA-24-182 closes 4/30/2031up to $180,144activenih
- Developing and validating the Communicating Needs with Care Partners Scale (CONNECT): a person-centered brain injury outcome measureEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-301 closes 4/30/2031up to $756,415activenih
- Characterizing and exploiting "allosteric crosstalk" amongst pain receptorsNational Institute on Drug AbuseRFA-DA-24-007 closes 4/30/2031up to $466,363activenih
- Gut Microbiota-Derived 3-PPA as a Metabolic Modulator of Beige Adipogenesis and Energy HomeostasisNational Institute of Diabetes and Digestive and Kidney DiseasesPA-25-301 closes 4/30/2031up to $786,728activenih
- Interdisciplinary Neurotrauma Research, Innovation, and Scientific Excellence (NEURO-RISE)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-168 closes 4/30/2031up to $100,522activenih
- DPT-PhD in Bioengineering Training Grant (T32)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-168 closes 4/30/2031up to $176,283activenih
- Vanderbilt Postdoctoral Education and Discovery in Systems Science (VPEDS)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-168 closes 4/30/2031up to $212,293activenih
- Mechanisms and pharmacotherapy of neurocognitive deficits in FASDNational Institute on Alcohol Abuse and AlcoholismPA-25-301 closes 4/30/2031up to $648,180activenih
- Development of transformative antibiotic-sparing therapeuticsNational Institute of Allergy and Infectious DiseasesRFA-AI-24-074 closes 4/30/2031up to $716,998activenih
- Systematic characterization of human disease associated protein complexesNational Institute of General Medical SciencesPAR-22-180 closes 4/30/2031up to $380,350activenih
- Novel approaches to predict strength and breadth of influenza vaccine responseNational Institute of Allergy and Infectious DiseasesPA-25-301 closes 4/30/2031up to $805,866activenih
- Neurodegenerative disease aggregation of TAF15National Institute of Neurological Disorders and StrokePA-25-301 closes 4/30/2031up to $645,448activenih
- Origin and trafficking of neutrophil-derived antigen-presenting cells (nAPCs)National Institute of Allergy and Infectious DiseasesPAR-22-225 closes 4/30/2031up to $576,529activenih
- Congenital Syphilis Treatment Trial (CONSISTENT): Phase IV, Open-label, Randomized Controlled Trial of Amoxicillin vs Benzathine Penicillin in Neonates with Possible Congenital SyphilisNational Institute of Allergy and Infectious DiseasesPAR-24-100 closes 4/30/2031up to $2,336,069activenih
- ADAR1 promotes Okazaki fragment maturation and is a target for breast cancer therapyNational Cancer InstitutePA-25-301 closes 4/30/2031up to $589,841activenih